Mortality associated with early changes in ARDS severity in COVID–19 patients – Insights from the PRoVENT–COVID study
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Critical Care"
DOI: 10.1016/j.jcrc.2021.06.016
Abstract: Purpose We investigated changes in ARDS severity and associations with outcome in COVID–19 ARDS patients. Methods We compared outcomes in patients with ARDS classified as ‘mild’, ‘moderate’ or ‘severe’ at calendar day 1, and after… read more here.
Keywords: ards severity; changes ards; mortality; severity ... See more keywords
Ketamine infusion as a sedative-analgesic in severe ARDS (KISS)
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Community Hospital Internal Medicine Perspectives"
DOI: 10.1080/20009666.2021.1948669
Abstract: ABSTRACT Rationale Ketamine has been used as a sedative analgesic in trauma setting, but data regarding its efficacy and safety is lacking in severe ARDS. This retrospective study aims to determine if Ketamine is safer… read more here.
Keywords: non ketamine; sedative analgesic; group; ketamine group ... See more keywords
626: PULMONARY COCCIDIOIDOMYCOSIS PRESENTING AS SEVERE ARDS IN A PEDIATRIC PATIENT
Sign Up to like & getrecommendations! Published in 2020 at "Critical Care Medicine"
DOI: 10.1097/01.ccm.0000626244.47430.f6
Abstract: Introduction: Valley Fever (Coccidioidomycosis (CM)) is growing as a public health challenge with increasing incidence over the last 15 years. Due to its nonspecific presentation, diagnosis and treatment are often delayed. Here we present a… read more here.
Keywords: coccidioidomycosis presenting; pulmonary coccidioidomycosis; 626 pulmonary; coccidioidomycosis ... See more keywords
Obstructive sleep apnea is highly prevalent in COVID19 moderate to severe ARDS survivors: Findings of level I Polysomnography in a tertiary care hospital
Sign Up to like & getrecommendations! Published in 2021 at "Sleep Medicine"
DOI: 10.1101/2021.05.04.21256593
Abstract: Study Objectives- Studies have found Obstructive Sleep Apnea (OSA) as a risk factor for increased risk for COVID19 Acute respiratory Distress Syndrome (ARDS); but most of the studies were done in already known patients of… read more here.
Keywords: covid19 moderate; apnea; covid19; severe ards ... See more keywords
A novel risk score for severe ARDS patients undergoing ECMO after retrieval from peripheral hospitals
Sign Up to like & getrecommendations! Published in 2018 at "Acta Anaesthesiologica Scandinavica"
DOI: 10.1111/aas.13022
Abstract: Extracorporeal Membrane Oxygenation in severe ARDS unresponsive to conventional protective ventilation is associated with elevated costs, resource and complications, and appropriate risk stratification of candidate patients could be useful to recognize those more likely to… read more here.
Keywords: risk; score severe; risk score; novel risk ... See more keywords
Reclassifying Acute Respiratory Distress Syndrome
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Respiratory and Critical Care Medicine"
DOI: 10.1164/rccm.201709-1804oc
Abstract: Rationale: The ratio of PaO2 to FiO2 (P/F) defines acute respiratory distress syndrome (ARDS) severity and suggests appropriate therapies. Objectives: We investigated 1) whether a 150‐mm‐Hg P/F threshold within the range of moderate ARDS (100‐200… read more here.
Keywords: distress syndrome; acute respiratory; respiratory distress; fio2 ... See more keywords
Early assessment of the efficacy of noninvasive ventilation tested by HACOR score to avoid delayed intubation in patients with moderate to severe ARDS
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Respiratory Disease"
DOI: 10.1177/17534666221081042
Abstract: Background: Use of noninvasive ventilation (NIV) in patients with moderate to severe ARDS is controversial. We aimed to use HACOR (combination of heart rate, acidosis, consciousness, oxygenation and respiratory rate) score to comprehensively assess the… read more here.
Keywords: hacor score; severe ards; intubation; moderate severe ... See more keywords
Severe ARDS Secondary to Legionella Pneumonia Requiring VV ECMO in the Setting of Newly Diagnosed Hairy Cell Leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Investigative Medicine High Impact Case Reports"
DOI: 10.1177/23247096211065618
Abstract: Venovenous (VV) extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) is initiated in patients with high mortality as a potential lifesaving intervention. Hematologic malignancy (HM) is considered a relative exclusion criterion by… read more here.
Keywords: hairy cell; hairy; severe ards; cell leukemia ... See more keywords
The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
Sign Up to like & getrecommendations! Published in 2020 at "Critical Care"
DOI: 10.1186/s13054-020-02947-x
Abstract: We read with interest the recent meta-analysis by Chang et al. who investigated the role of neuromuscular blocking agent (NMBA) use in moderate-to-severe acute respiratory distress syndrome (ARDS) and discuss the potential mechanisms involved in… read more here.
Keywords: neuromuscular blocking; moderate ards; mortality; severe ards ... See more keywords
Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Intensive Care"
DOI: 10.1186/s13613-019-0556-1
Abstract: BackgroundVenovenous extracorporeal membrane oxygenation (VV-ECMO) is associated with a significant morbidity. There is the need to investigate long-term cognitive outcome among ARDS survivors treated with VV-ECMO. We aimed to compare the prevalence of long-term cognitive… read more here.
Keywords: ecmo patients; outcome; long term; non ecmo ... See more keywords
Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Intensive Care"
DOI: 10.1186/s13613-019-0616-6
Abstract: BackgroundHerpesviridae reactivation among non-immunocompromised critically ill patients is associated with impaired prognosis, especially during acute respiratory distress syndrome (ARDS). However, little is known about herpes simplex virus (HSV) and Cytomegalovirus (CMV) reactivation occurring in patients… read more here.
Keywords: cmv reactivation; longer duration; ecmo; reactivation ... See more keywords